Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders

Biochemical Pharmacology

Volumn 98, Issue 1, 2015, Pages 1-15

  Koeberle, Andreas ^a   Werz, Oliver ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Eicosanoid; Inflammation; Lipid mediator; Micrososmal prostaglandin E2 synthase 1; NSAID

Indexed keywords

FATTY ACID; ICOSANOID; LIPID; LIPOXYGENASE INHIBITOR; PROSTAGLANDIN E1; PROSTAGLANDIN E2; ISOMERASE; PROSTAGLANDIN E SYNTHASE;

DRUG TARGETING; FATTY ACID SYNTHESIS; GENE EXPRESSION; HUMAN; INFLAMMATION; MOLECULAR MECHANICS; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; DRUG DEVELOPMENT; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SPECIES DIFFERENCE;

ANIMALS; DINOPROSTONE; DRUG DISCOVERY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTRAMOLECULAR OXIDOREDUCTASES; MOLECULAR STRUCTURE; SPECIES SPECIFICITY;

EID: 84943587206     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2015.06.022     Document Type: Note

References (112)

1. A. Koeberle, and O. Werz Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs) - a critical review Curr. Med. Chem. 16 2009 4274 4296
2. T. Grosser, Y. Yu, and G.A. Fitzgerald Emotion recollected in tranquility: lessons learned from the COX-2 saga Ann. Rev. Med. 61 2010 17 33
3. P.M. Kearney, C. Baigent, J. Godwin, H. Halls, J.R. Emberson, and C. Patrono Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials Br. Med. J. 332 2006 1302 1308
4. B. Samuelsson, R. Morgenstern, and P.J. Jakobsson Membrane prostaglandin E synthase-1: a novel therapeutic target Pharmacol. Rev. 59 2007 207 224
5. M.J. Stables, and D.W. Gilroy Old and new generation lipid mediators in acute inflammation and resolution Prog. Lipid. Res. 50 2011 35 51
6. S. Hara, D. Kamei, Y. Sasaki, A. Tanemoto, Y. Nakatani, and M. Murakami Prostaglandin E synthases: understanding their pathophysiological roles through mouse genetic models Biochimie 92 2010 651 659
7. A. Schneider, Y. Zhang, M. Zhang, W.J. Lu, R. Rao, X. Fan, and et al. Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney Kidney Int. 65 2004 1205 1213
8. G. Folco, and R.C. Murphy Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses Pharmacol. Rev. 58 2006 375 388
9. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat. Immunol. 2 2001 612 619
10. A.D. Mancini, and J.A. Di Battista The cardinal role of the phospholipase A(2)/cyclooxygenase-2/prostaglandin E synthase/prostaglandin E(2) (PCPP) axis in inflammostasis Inflamm. Res. 60 2011 1083 1092
11. M.S. Bahia, Y.K. Katare, O. Silakari, B. Vyas, and P. Silakari Inhibitors of microsomal prostaglandin E2 synthase-1 enzyme as emerging anti-inflammatory candidates Med. Res. Rev. 34 2014 825 855
12. V. Konya, G. Marsche, R. Schuligoi, and A. Heinemann E-type prostanoid receptor 4 (EP4) in disease and therapy Pharmacol. Ther. 138 2013 485 502
13. M. Wang, and G.A. Fitzgerald Cardiovascular biology of microsomal prostaglandin E synthase-1 Trends Cardiovasc. Med. 20 2010 189 195
14. K. Scholich, and G. Geisslinger Is mPGES-1 a promising target for pain therapy? Trends Pharmacol. Sci. 27 2006 399 401
15. O. Radmark, and B. Samuelsson Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer J. Intern. Med. 268 2010 5 14
16. B. Wei, L. Cai, D. Sun, Y. Wang, C. Wang, X. Chai, and et al. Microsomal prostaglandin E synthase-1 deficiency exacerbates pulmonary fibrosis induced by bleomycin in mice Molecules 19 2014 4967 4985
17. C. Brenneis, O. Coste, K. Altenrath, C. Angioni, H. Schmidt, C.D. Schuh, and et al. Anti-inflammatory role of microsomal prostaglandin E synthase-1 in a model of neuroinflammation J. Biol. Chem. 286 2011 2331 2342
18. A. Frolov, L. Yang, H. Dong, B.D. Hammock, and L.J. Crofford Anti-inflammatory properties of prostaglandin E2: deletion of microsomal prostaglandin E synthase-1 exacerbates non-immune inflammatory arthritis in mice Prostaglandins Leukot. Essent. Fatty Acids 89 2013 351 358
19. F. Salazar, M.L. Vazquez, J.L. Masferrer, G. Mbalaviele, M.T. Llinas, F. Saez, and et al. Renal effects induced by prolonged mPGES1 inhibition Am. J. Physiol. Renal. Physiol. 306 2014 F68 F74
20. H. Francois, C. Facemire, A. Kumar, L. Audoly, B. Koller, and T. Coffman Role of microsomal prostaglandin E synthase 1 in the kidney J. Am. Soc. Nephrol. 18 2007 1466 1475
21. Z. Jia, Y. Sun, S. Liu, Y. Liu, and T. Yang COX-2 but not mPGES-1 contributes to renal PGE2 induction and diabetic proteinuria in mice with type-1 diabetes PLoS ONE 9 2014 e93182
22. Z. Jia, H. Wang, and T. Yang Microsomal prostaglandin E synthase 1 deletion retards renal disease progression but exacerbates anemia in mice with renal mass reduction Hypertension 59 2012 122 128
23. S. Soodvilai, Z. Jia, M.H. Wang, Z. Dong, and T. Yang mPGES-1 deletion impairs diuretic response to acute water loading Am. J. Physiol. Renal. Physiol. 296 2009 F1129 F1135
24. Z. Jia, G. Liu, M. Downton, Z. Dong, A. Zhang, and T. Yang mPGES-1 deletion potentiates urine concentrating capability after water deprivation Am. J. Physiol. Renal. Physiol. 302 2012 F1005 F1012
25. Z. Jia, G. Liu, Y. Sun, Y. Kakizoe, G. Guan, A. Zhang, and et al. mPGES-1-derived PGE2 mediates dehydration natriuresis Am. J. Physiol. Renal. Physiol. 304 2013 F214 F221
26. Y. Cheng, M. Wang, Y. Yu, J. Lawson, C.D. Funk, and G.A. Fitzgerald Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function J. Clin. Invest. 116 2006 1391 1399
27. M. Wang, K. Ihida-Stansbury, D. Kothapalli, M.C. Tamby, Z. Yu, L. Chen, and et al. Microsomal prostaglandin e2 synthase-1 modulates the response to vascular injury Circulation 123 2011 631 639
28. L. Chen, G. Yang, J. Monslow, L. Todd, D.P. Cormode, J. Tang, and et al. Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice Proc. Natl. Acad. Sci. U.S.A. 111 2014 6828 6833
29. L. Chen, G. Yang, X. Xu, G. Grant, J.A. Lawson, Y.M. Bohlooly, and et al. Cell selective cardiovascular biology of microsomal prostaglandin E synthase-1 Circulation 127 2013 233 243
30. P.J. Jakobsson, S. Thoren, R. Morgenstern, and B. Samuelsson Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target Proc. Natl. Acad. Sci. U.S.A. 96 1999 7220 7225
31. T. Sjögren, J. Nord, M. Ek, P. Johansson, G. Liu, and S. Geschwindner Crystal structure of microsomal prostaglandin E2 synthase provides insight into diversity in the MAPEG superfamily Proc. Natl. Acad. Sci. U.S.A. 110 2013 3806 3811
32. C. Jegerschold, S.C. Pawelzik, P. Purhonen, P. Bhakat, K.R. Gheorghe, N. Gyobu, and et al. Structural basis for induced formation of the inflammatory mediator prostaglandin E2 Proc. Natl. Acad. Sci. U.S.A. 105 2008 11110 11115
33. S.C. Pawelzik, N.R. Uda, L. Spahiu, C. Jegerschold, P. Stenberg, H. Hebert, and et al. Identification of key residues determining species differences in inhibitor binding of microsomal prostaglandin E synthase-1 J. Biol. Chem. 285 2010 29254 29261
34. S. He, Y. Wu, D. Yu, and L. Lai Microsomal prostaglandin E synthase-1 exhibits one-third-of-the-sites reactivity Biochem. J. 440 2011 13 21
35. H. Ago, Y. Kanaoka, D. Irikura, B.K. Lam, T. Shimamura, K.F. Austen, and et al. Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis Nature 448 2007 609 612
36. T. Hammarberg, M. Hamberg, A. Wetterholm, H. Hansson, B. Samuelsson, and J.Z. Haeggstrom Mutation of a critical arginine in microsomal PGE synthase-1 shifts the isomerase activity to a reductase activity that converts prostaglandin H2 into prostaglandin F2alpha J. Biol. Chem. 284 2008 301 305
37. E.B. Prage, S.C. Pawelzik, L.S. Busenlehner, K. Kim, R. Morgenstern, P.J. Jakobsson, and et al. Location of inhibitor binding sites in the human inducible prostaglandin E synthase, MPGES1 Biochemistry 50 2011 7684 7693
38. D. Li, N. Howe, A. Dukkipati, S.T. Shah, B.D. Bax, C. Edge, and et al. Crystallizing membrane proteins in the lipidic mesophase. Experience with human prostaglandin E2 synthase 1 and an evolving strategy Cryst. Growth Des. 14 2014 2034 2047
39. J.G. Luz, S. Antonysamy, S.L. Kuklish, B. Condon, M.R. Lee, D. Allison, and et al. Crystal structures of mPGES-1 inhibitor complexes form a basis for the rational design of potent analgesic and anti-inflammatory therapeutics J. Med. Chem. 58 2015 4727 4737
40. L. Forsberg, L. Leeb, S. Thoren, R. Morgenstern, and P. Jakobsson Human glutathione dependent prostaglandin E synthase: gene structure and regulation FEBS Lett. 471 2000 78 82
41. L. Ekstrom, L. Lyrenas, P.J. Jakobsson, R. Morgenstern, and M.J. Kelner Basal expression of the human MAPEG members microsomal glutathione transferase 1 and prostaglandin E synthase genes is mediated by Sp1 and Sp3 Biochim. Biophys. Acta. 1627 2003 79 84
42. J.N. Walters, J.S. Bickford, K.J. Newsom, D.E. Beachy, S.J. Barilovits, J.D. Herlihy, and et al. Regulation of human microsomal prostaglandin E synthase-1 by IL-1beta requires a distal enhancer element with a unique role for C/EBPbeta Biochem. J. 443 2012 561 571
43. M.D. Diaz-Munoz, I.C. Osma-Garcia, C. Cacheiro-Llaguno, M. Fresno, and M.A. Iniguez Coordinated up-regulation of cyclooxygenase-2 and microsomal prostaglandin E synthase 1 transcription by nuclear factor kappa B and early growth response-1 in macrophages Cell. Signal. 22 2010 1427 1436
44. X. Xue, and Y.M. Shah Hypoxia-inducible factor-2alpha is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer Carcinogenesis 34 2013 163 169
45. M.D. Diaz-Munoz, I.C. Osma-Garcia, M. Fresno, and M.A. Iniguez Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages Biochem. J. 443 2012 451 461
46. S. Cheng, H. Afif, J. Martel-Pelletier, J.P. Pelletier, X. Li, K. Farrajota, and et al. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1 J. Biol. Chem. 279 2004 22057 22065
47. L. Xiao, M. Ornatowska, G. Zhao, H. Cao, R. Yu, J. Deng, and et al. Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages PLoS ONE 7 2012 e50244
48. M. Murakami, K. Nakashima, D. Kamei, S. Masuda, Y. Ishikawa, T. Ishii, and et al. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2 J. Biol. Chem. 278 2003 37937 37947
49. J.A. Mancini, K. Blood, J. Guay, R. Gordon, D. Claveau, C.C. Chan, and et al. Cloning, expression, and up-regulation of inducible rat prostaglandin e synthase during lipopolysaccharide-induced pyresis and adjuvant-induced arthritis J. Biol. Chem. 276 2001 4469 4475
50. M. Lazarus, N. Eguchi, S. Matsumoto, N. Nagata, T. Yano, G.J. Killian, and et al. Species-specific expression of microsomal prostaglandin E synthase-1 and cyclooxygenases in male monkey reproductive organs Prostaglandins Leukot. Essent. Fatty Acids 71 2004 233 240
51. T. Tanioka, Y. Nakatani, N. Semmyo, M. Murakami, and I. Kudo Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis J. Biol. Chem. 275 2000 32775 32782
52. N. Tanikawa, Y. Ohmiya, H. Ohkubo, K. Hashimoto, K. Kangawa, M. Kojima, and et al. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase Biochem. Biophys. Res. Commun. 291 2002 884 889
53. F. Takusagawa Microsomal prostaglandin E synthase type 2 (mPGES2) is a glutathione-dependent heme protein, and dithiothreitol dissociates the bound heme to produce active prostaglandin E2 synthase in vitro J. Biol. Chem. 288 2013 10166 10175
54. T. Kihara, Y. Shimmyo, A. Akaike, T. Niidome, and H. Sugimoto Abeta-induced BACE-1 cleaves N-terminal sequence of mPGES-2 Biochem. Biophys. Res. Commun. 393 2010 728 733
55. U. Chaudhry, H. Zhuang, and S. Dore Microsomal prostaglandin E synthase-2: cellular distribution and expression in Alzheimer's disease Exp. Neurol. 223 2010 359 365
56. S. Mattila, H. Tuominen, J. Koivukangas, and F. Stenback The terminal prostaglandin synthases mPGES-1, mPGES-2, and cPGES are all overexpressed in human gliomas Neuropathology 29 2009 156 165
57. L.A. Jania, S. Chandrasekharan, M.G. Backlund, N.A. Foley, J. Snouwaert, I.M. Wang, and et al. Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis Prostaglandins Other Lipid Mediat. 88 2009 73 81
58. Y. Sun, Z. Jia, G. Yang, Y. Kakizoe, M. Liu, K.T. Yang, and et al. mPGES-2 deletion remarkably enhances liver injury in streptozotocin-treated mice via induction of GLUT2 J. Hepatol. 61 2014 1328 1336
59. J.K. Norberg, E. Sells, H.H. Chang, S.R. Alla, S. Zhang, and E.J. Meuillet Targeting inflammation: multiple innovative ways to reduce prostaglandin E(2) Pharm. Pat. Anal. 2 2013 265 288
60. M. Korotkova, and P.J. Jakobsson Characterization of microsomal prostaglandin E synthase 1 inhibitors Basic Clin. Pharmacol. Toxicol. 114 2014 64 69
61. S. Thoren, and P.J. Jakobsson Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4 Eur. J. Biochem. 267 2000 6428 6434
62. M. David Percival Continuous spectrophotometric assay amenable to 96-well plate format for prostaglandin E synthase activity Anal. Biochem. 313 2003 307 310
63. E.R. Goedken, A.I. Gagnon, G.T. Overmeyer, J. Liu, R.A. Petrillo, A.F. Burchat, and et al. HTRF-based assay for microsomal prostaglandin E2 synthase-1 activity J. Biomol. Screening 13 2008 619 625
64. L. Spahiu, P. Stenberg, C. Larsson, J. Wannberg, M. Alterman, B. Kull, and et al. A facilitated approach to evaluate the inhibitor mode and potency of compounds targeting microsomal prostaglandin e synthase-1 Assay Drug Dev. Technol. 9 2011 487 495
65. A. Wiegard, W. Hanekamp, K. Griessbach, J. Fabian, and M. Lehr Pyrrole alkanoic acid derivatives as nuisance inhibitors of microsomal prostaglandin E2 synthase-1 Eur. J. Med. Chem. 48 2012 153 163
66. A. Koeberle, A. Rossi, J. Bauer, F. Dehm, L. Verotta, H. Northoff, and et al. Hyperforin, an anti-inflammatory constituent from St. John's Wort, inhibits microsomal prostaglandin E(2) synthase-1 and suppresses prostaglandin E(2) formation in vivo Front. Pharmacol. 2 2011 7
67. A. Koeberle, U. Siemoneit, U. Buhring, H. Northoff, S. Laufer, W. Albrecht, and et al. Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1 J. Pharmacol. Exp. Ther. 326 2008 975 982
68. B. Cote, L. Boulet, C. Brideau, D. Claveau, D. Ethier, R. Frenette, and et al. Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors Bioorg. Med. Chem. Lett. 17 2007 6816 6820
69. D. Riendeau, R. Aspiotis, D. Ethier, Y. Gareau, E.L. Grimm, J. Guay, and et al. Inhibitors of the inducible microsomal prostaglandin E2 synthase (mPGES-1) derived from MK-886 Bioorg. Med. Chem. Lett. 15 2005 3352 3355
70. D. Xu, S.E. Rowland, P. Clark, A. Giroux, B. Cote, S. Guiral, and et al. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation J. Pharmacol. Exp. Ther. 326 2008 754 763
71. I. Wobst, S. Schiffmann, K. Birod, T.J. Maier, R. Schmidt, C. Angioni, and et al. Dimethylcelecoxib inhibits prostaglandin E2 production Biochem. Pharmacol. 76 2008 62 69
72. M. Elkady, R. Niess, A.M. Schaible, J. Bauer, S. Luderer, G. Ambrosi, and et al. Modified acidic nonsteroidal anti-inflammatory drugs as dual inhibitors of mPGES-1 and 5-LOX J. Med. Chem. 55 2012 8958 8962
73. D. Claveau, M. Sirinyan, J. Guay, R. Gordon, C.C. Chan, Y. Bureau, and et al. Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model J. Immunol. 170 2003 4738 4744
74. J. Gillard, A.W. Ford-Hutchinson, C. Chan, S. Charleson, D. Denis, A. Foster, and et al. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor Can. J. Physiol. Pharmacol. 67 1989 456 464
75. A. Koeberle, U. Siemoneit, H. Northoff, B. Hofmann, G. Schneider, and O. Werz MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregation Eur. J. Pharmacol. 608 2009 84 90
76. A. Giroux, L. Boulet, C. Brideau, A. Chau, D. Claveau, B. Cote, and et al. Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors Bioorg. Med. Chem. Lett. 19 2009 5837 5841
77. T.Y. Wu, H. Juteau, Y. Ducharme, R.W. Friesen, S. Guiral, L. Dufresne, and et al. Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1 Bioorg. Med. Chem. Lett. 20 2010 6978 6982
78. J.F. Chiasson, L. Boulet, C. Brideau, A. Chau, D. Claveau, B. Cote, and et al. Trisubstituted ureas as potent and selective mPGES-1 inhibitors Bioorg. Med. Chem. Lett. 21 2011 1488 1492
79. J. Wang, D. Limburg, J. Carter, G. Mbalaviele, J. Gierse, and M. Vazquez Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template Bioorg. Med. Chem. Lett. 20 2010 1604 1609
80. G.B. Arhancet, D.P. Walker, S. Metz, Y.M. Fobian, S.E. Heasley, J.S. Carter, and et al. Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation Bioorg. Med. Chem. Lett. 23 2013 1114 1119
81. D.P. Walker, G.B. Arhancet, H.F. Lu, S.E. Heasley, S. Metz, N.M. Kablaoui, and et al. Synthesis and biological evaluation of substituted benzoxazoles as inhibitors of mPGES-1: use of a conformation-based hypothesis to facilitate compound design Bioorg. Med. Chem. Lett. 23 2013 1120 1126
82. T. Shiro, H. Takahashi, K. Kakiguchi, Y. Inoue, K. Masuda, H. Nagata, and et al. Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E(2) synthase-1 inhibitors Bioorg. Med. Chem. Lett. 22 2012 285 288
83. T. Shiro, K. Kakiguchi, H. Takahashi, H. Nagata, and M. Tobe Synthesis and biological evaluation of substituted imidazoquinoline derivatives as mPGES-1 inhibitors Bioorg. Med. Chem. 21 2013 2068 2078
84. T. Shiro, K. Kakiguchi, H. Takahashi, H. Nagata, and M. Tobe 7-Phenyl-imidazoquinolin-4(5H)-one derivatives as selective and orally available mPGES-1 inhibitors Bioorg. Med. Chem. 21 2013 2868 2878
85. A. Banerjee, M.Y. Pawar, S. Patil, P.S. Yadav, P.A. Kadam, V.G. Kattige, and et al. Development of 2-aryl substituted quinazolin-4(3H)-one, pyrido[4,3-d]pyrimidin-4(3H)-one and pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as microsomal prostaglandin E(2) synthase-1 inhibitors Bioorg. Med. Chem. Lett. 24 2014 4838 4844
86. A. Koeberle, H. Northoff, and O. Werz Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1 Mol. Cancer Ther. 8 2009 2348 2355
87. A. Koeberle, J. Bauer, M. Verhoff, M. Hoffmann, H. Northoff, and O. Werz Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E(2) synthase-1 Biochem. Biophys. Res. Commun. 388 2009 350 354
88. A. Koeberle, H. Northoff, and O. Werz Identification of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol Biochem. Pharmacol. 77 2009 1513 1521
89. U. Siemoneit, A. Koeberle, A. Rossi, F. Dehm, M. Verhoff, S. Reckel, and et al. Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense Br. J. Pharmacol. 162 2011 147 162
90. M. Verhoff, S. Seitz, M. Paul, S.M. Noha, J. Jauch, D. Schuster, and et al. Tetra- and pentacyclic triterpene acids from the ancient anti-inflammatory remedy frankincense as inhibitors of microsomal prostaglandin E(2) synthase-1 J. Nat. Prod. 77 2014 1445 1451
91. J. Bauer, S. Kuehnl, J.M. Rollinger, O. Scherer, H. Northoff, H. Stuppner, and et al. Carnosol and carnosic acids from Salvia officinalis inhibit microsomal prostaglandin E2 synthase-1 J. Pharmacol. Exp. Ther. 342 2012 169 176
92. A.M. Schaible, H. Traber, V. Temml, S.M. Noha, R. Filosa, A. Peduto, and et al. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E(2) synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin Biochem. Pharmacol. 86 2013 476 486
93. J. Bauer, A. Koeberle, F. Dehm, F. Pollastro, G. Appendino, H. Northoff, and et al. Arzanol, a prenylated heterodimeric phloroglucinyl pyrone, inhibits eicosanoid biosynthesis and exhibits anti-inflammatory efficacy in vivo Biochem. Pharmacol. 81 2011 259 268
94. A. Koeberle, F. Pollastro, H. Northoff, and O. Werz Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1 Br. J. Pharmacol. 156 2009 952 961
95. J. Bauer, B. Waltenberger, S.M. Noha, D. Schuster, J.M. Rollinger, J. Boustie, and et al. Discovery of depsides and depsidones from lichen as potent inhibitors of microsomal prostaglandin E2 synthase-1 using pharmacophore models ChemMedChem 7 2012 2077 2081
96. L. Baumgartner, S. Sosa, A.G. Atanasov, A. Bodensieck, N. Fakhrudin, J. Bauer, and et al. Lignan derivatives from Krameria lappacea roots inhibit acute inflammation in vivo and pro-inflammatory mediators in vitro J. Nat. Prod. 74 2011 1779 1786
97. F. Celotti, and S. Laufer Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept Pharmacol. Res. 43 2001 429 436
98. L. Fischer, M. Hornig, C. Pergola, N. Meindl, L. Franke, Y. Tanrikulu, and et al. The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products Br. J. Pharmacol. 152 2007 471 480
99. S.K. Kulkarni, and V.P. Singh Licofelone: the answer to unmet needs in osteoarthritis therapy? Curr. Rheumatol. Rep. 10 2008 43 48
100. A. Koeberle, H. Zettl, C. Greiner, M. Wurglics, M. Schubert-Zsilavecz, and O. Werz Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase J. Med. Chem. 51 2008 8068 8076
101. A. Koeberle, A. Rossi, H. Zettl, C. Pergola, F. Dehm, J. Bauer, and et al. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase J. Pharmacol. Exp. Ther. 332 2010 840 848
102. M. Hieke, C. Greiner, M. Dittrich, F. Reisen, G. Schneider, M. Schubert-Zsilavecz, and et al. Discovery and biological evaluation of a novel class of dual microsomal prostaglandin E2 synthase-1/5-lipoxygenase inhibitors based on 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid J. Med. Chem. 54 2011 4490 4507
103. T. Hanke, F. Dehm, S. Liening, S.D. Popella, J. Maczewsky, M. Pillong, and et al. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo J. Med. Chem. 56 2013 9031 9044
104. E.M. Karg, S. Luderer, C. Pergola, U. Buhring, A. Rossi, H. Northoff, and et al. Structural optimization and biological evaluation of 2-substituted 5-hydroxyindole-3-carboxylates as potent inhibitors of human 5-lipoxygenase J. Med. Chem. 52 2009 3474 3483
105. A. Koeberle, E.M. Haberl, A. Rossi, C. Pergola, F. Dehm, H. Northoff, and et al. Discovery of benzo[g]indol-3-carboxylates as potent inhibitors of microsomal prostaglandin E(2) synthase-1 Bioorg. Med. Chem. 17 2009 7924 7932
106. H. Idborg, P. Olsson, P. Leclerc, J. Raouf, P.J. Jakobsson, and M. Korotkova Effects of mPGES-1 deletion on eicosanoid and fatty acid profiles in mice Prostaglandins Other Lipid Mediat. 107 2013 18 25
107. A. Koeberle, H. Shindou, S.C. Koeberle, S.A. Laufer, T. Shimizu, and O. Werz Arachidonoyl-phosphatidylcholine oscillates during the cell cycle and counteracts proliferation by suppressing Akt membrane binding Proc. Natl. Acad. Sci. U.S.A. 110 2013 2546 2551
108. A. Koeberle, H. Shindou, T. Harayama, and T. Shimizu Palmitoleate is a mitogen, formed upon stimulation with growth factors, and converted to palmitoleoyl-phosphatidylinositol J. Biol. Chem. 287 2012 27244 27254
109. A. Koeberle, C. Pergola, H. Shindou, S.C. Koeberle, T. Shimizu, S.A. Laufer, and et al. Role of p38 mitogen-activated protein kinase in linking stearoyl-CoA desaturase-1 activity with endoplasmic reticulum homeostasis FASEB J. 2015
110. T.J. Maier, L. Tausch, M. Hoernig, O. Coste, R. Schmidt, C. Angioni, and et al. Celecoxib inhibits 5-lipoxygenase Biochem. Pharmacol. 76 2008 862 872
111. P. Leclerc, H. Idborg, L. Spahiu, C. Larsson, N. Nekhotiaeva, J. Wannberg, and et al. Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation Prostaglandins Other Lipid Mediat. 107 2013 26 34
112. D.V. Jovanovic, J.C. Fernandes, J. Martel-Pelletier, F.C. Jolicoeur, P. Reboul, S. Laufer, and et al. In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis: suppression of collagenase 1 and interleukin-1beta synthesis Arthritis Rheum. 44 2001 2320 2330